Evidence map›Paper›PMID 32766303›Full record

ArticleBioMed research international2020

Secondary Metabolites of

Ali A Shati, Mohammed A Alkahtani, Mohamed Y Alfaifi, Serag Eldin I Elbehairi, Fahmy G Elsaid, Rajagopalan Prasanna, Mushtaq A Mir

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 33 citations in OpenAlex.

  1. RSC advances · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Frontiers in pharmacology · 2025
    Review
  6. Review
  7. Antimycobacterial and Anticancer Properties ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Article
  10. Comparison of the Anti-bacterial Efficacy ofFrontiers in oral health · 2022
    Article
  11. Current issues in molecular biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Ali A ShatiBiology Department, Faculty of Science, King Khalid University, Abha 9004, Saudi Arabia.
Mohammed A AlkahtaniBiology Department, Faculty of Science, King Khalid University, Abha 9004, Saudi Arabia.
Mohamed Y AlfaifiBiology Department, Faculty of Science, King Khalid University, Abha 9004, Saudi Arabia.
Serag Eldin I ElbehairiBiology Department, Faculty of Science, King Khalid University, Abha 9004, Saudi Arabia.
Fahmy G ElsaidBiology Department, Faculty of Science, King Khalid University, Abha 9004, Saudi Arabia.ORCID https://orcid.org/0000-0002-7754-2524
Rajagopalan PrasannaDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, P. O. Box 3665, Abha 61421, Saudi Arabia.
Mushtaq A MirDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, P. O. Box 3665, Abha 61421, Saudi Arabia.ORCID https://orcid.org/0000-0002-4388-1165
King Khalid University · SAMansoura University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundApoptosis, a major form of programmed cell death, plays a vital role in regulating tissue development and maintenance of homeostasis in eukaryotes. Apoptosis can occur via a death receptor-dependent extrinsic or a mitochondrial-dependent intrinsic pathway and can be induced by various chemotherapeutic agents. In this study, the anticancer activity of

resultsIn this study, the bioactives of

conclusionThese results suggest that the

Indexed as

ApoptosisBreast NeoplasmsCaspase 3Cell CycleCell ProliferationColonic NeoplasmsFemaleHumansLiver NeoplasmsMetabolomePhytochemicalsPlant ExtractsPlant LeavesSaussureaTumor Cells, CulturedCaspase 3PhytochemicalsPlant Extracts

Identifiers

PMID32766303
PMCPMC7374224
OpenAlexW3041510940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.